By using network pharmacology and molecular docking technique, we revealed the effect of QBD with DHA, ART, and CA as the active ingredients, MAPK1 and PI3K as the important targets, and the important pathways of MAPK and PI3K/AKT on the intervention on the inflammation-carcinoma transformation process of chronic liver disease. This evidence concerns the gene PIK3CA and carcinoma.